BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25341134)

  • 1. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
    Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes.
    Gupta R; Mortelé KJ; Tatli S; Girshman J; Glickman JN; Levy AD; Erturk SM; Heffess CS; Banks PA; Silverman SG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1458-64. PubMed ID: 18941085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
    Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
    AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasms with associated invasive carcinoma of the pancreas: imaging findings and diagnostic performance of MDCT for prediction of prognostic factors.
    Kim JH; Eun HW; Kim KW; Lee JY; Lee JM; Han JK; Choi BI
    AJR Am J Roentgenol; 2013 Sep; 201(3):565-72. PubMed ID: 23971447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical CT features with pathologic findings.
    Liu Y; Lin X; Upadhyaya M; Song Q; Chen K
    Eur J Radiol; 2010 Nov; 76(2):222-7. PubMed ID: 19586733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
    Zhang J; Wang PJ; Yuan XD
    Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MR imaging features of fistulas from intraductal papillary mucinous neoplasms of the pancreas to adjacent organs: A retrospective study of 423 patients.
    Ravaud S; Laurent V; Jausset F; Cannard L; Mandry D; Oliver A; Claudon M
    Eur J Radiol; 2015 Nov; 84(11):2080-8. PubMed ID: 26321495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up.
    Uehara H; Ishikawa O; Katayama K; Kawada N; Ikezawa K; Fukutake N; Takakura R; Takano Y; Tanaka S; Takenaka A
    J Gastroenterol; 2011 May; 46(5):657-63. PubMed ID: 21085997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
    D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
    Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
    Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
    Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
    Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
    Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.